| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zynerba Pharmaceuticals, Inc. | Director | Common Stock | 0 | $1.33 | 10 Oct 2023 | Direct | |
| Zynerba Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 10 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000114036123047731-cooper-warren-d-2023-10-10 | Zynerba Pharmaceuticals, Inc. | 10 Oct 2023 | 4 | $0 | 4 | Director | 11 Oct 2023, 10:03 |
| /report/000106299323013663-cooper-warren-d-2023-06-13 | Zynerba Pharmaceuticals, Inc. | 13 Jun 2023 | 3 | -$40.03 | 4 | Director | 15 Jun 2023, 16:28 |
| /report/000106299322015038-cooper-warren-d-2022-06-14 | Zynerba Pharmaceuticals, Inc. | 14 Jun 2022 | 3 | -$40.4 | 4 | Director | 16 Jun 2022, 21:49 |
| /report/000119248221000643-cooper-warren-d-2021-08-03 | Zynerba Pharmaceuticals, Inc. | 03 Aug 2021 | 2 | $0 | 4 | Director | 05 Aug 2021, 17:23 |